This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Natco Pharma Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations by Rama Krishna Pilli in Anticancer Drug Development
Introduction
Rama Krishna Pilli is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. His innovative work has led to the creation of a novel series of compounds that hold promise in cancer treatment.
Latest Patents
Rama Krishna Pilli holds a patent for his invention titled "7-(morpholinyl)-2-(N-piperazinyl) methyl thieno [2, 3-C] pyridine derivatives as anticancer drugs." This patent describes a unique series of substituted 7-(morpholinyl)-2-(N-piperazinyl)-methyl thieno [2, 3-c] pyridines, which are designed to target cancer cells effectively. The structural formula of these compounds includes specific definitions for R1, R2, R3, and R4, highlighting the innovative nature of his work.
Career Highlights
Rama Krishna Pilli is currently associated with Natco Pharma Limited, a prominent pharmaceutical company known for its focus on developing high-quality medicines. His role at Natco Pharma has allowed him to leverage his expertise in drug development and contribute to the advancement of cancer therapies.
Collaborations
Throughout his career, Rama Krishna Pilli has collaborated with talented professionals in the field
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile